Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Plasticity and Clonality of Cancer Cell States.

Barkley D, Yanai I.

Trends Cancer. 2019 Nov;5(11):655-656. doi: 10.1016/j.trecan.2019.09.002. Epub 2019 Oct 14.

PMID:
31735281
2.

Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.

Kim JY, Gatenby RA.

Methods Mol Biol. 2017;1513:61-81. Review.

PMID:
27807831
3.

Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.

Fan J, Lee HO, Lee S, Ryu DE, Lee S, Xue C, Kim SJ, Kim K, Barkas N, Park PJ, Park WY, Kharchenko PV.

Genome Res. 2018 Aug;28(8):1217-1227. doi: 10.1101/gr.228080.117. Epub 2018 Jun 13.

4.

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suvà ML, Regev A, Bernstein BE.

Science. 2014 Jun 20;344(6190):1396-401. doi: 10.1126/science.1254257. Epub 2014 Jun 12.

5.

Glioblastoma heterogeneity and cancer cell plasticity.

Friedmann-Morvinski D.

Crit Rev Oncog. 2014;19(5):327-36. Review.

PMID:
25404148
6.

Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma.

Parker NR, Hudson AL, Khong P, Parkinson JF, Dwight T, Ikin RJ, Zhu Y, Cheng ZJ, Vafaee F, Chen J, Wheeler HR, Howell VM.

Sci Rep. 2016 Mar 4;6:22477. doi: 10.1038/srep22477.

7.

Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications.

Bernstock JD, Mooney JH, Ilyas A, Chagoya G, Estevez-Ordonez D, Ibrahim A, Nakano I.

J Neurosurg. 2019 Aug 23:1-9. doi: 10.3171/2019.5.JNS19364. [Epub ahead of print] Review.

PMID:
31443071
8.
9.

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.

Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez EM, Gonzalez Castro LN, Lan X, Druck N, Rodman C, Dionne D, Kaplan A, Bertalan MS, Small J, Pelton K, Becker S, Bonal D, Nguyen QD, Servis RL, Fung JM, Mylvaganam R, Mayr L, Gojo J, Haberler C, Geyeregger R, Czech T, Slavc I, Nahed BV, Curry WT, Carter BS, Wakimoto H, Brastianos PK, Batchelor TT, Stemmer-Rachamimov A, Martinez-Lage M, Frosch MP, Stamenkovic I, Riggi N, Rheinbay E, Monje M, Rozenblatt-Rosen O, Cahill DP, Patel AP, Hunter T, Verma IM, Ligon KL, Louis DN, Regev A, Bernstein BE, Tirosh I, Suvà ML.

Cell. 2019 Aug 8;178(4):835-849.e21. doi: 10.1016/j.cell.2019.06.024. Epub 2019 Jul 18.

PMID:
31327527
10.

Androgen deprivation induces phenotypic plasticity and promotes resistance to molecular targeted therapy in a PTEN-deficient mouse model of prostate cancer.

De Velasco MA, Tanaka M, Yamamoto Y, Hatanaka Y, Koike H, Nishio K, Yoshikawa K, Uemura H.

Carcinogenesis. 2014 Sep;35(9):2142-53. doi: 10.1093/carcin/bgu143. Epub 2014 Jul 1.

11.

Comparison of glioblastoma (GBM) molecular classification methods.

Lee E, Yong RL, Paddison P, Zhu J.

Semin Cancer Biol. 2018 Dec;53:201-211. doi: 10.1016/j.semcancer.2018.07.006. Epub 2018 Jul 19. Review.

PMID:
30031763
12.

Microenvironmental Signals and Biochemical Information Processing: Cooperative Determinants of Intratumoral Plasticity and Heterogeneity.

Davies AE, Albeck JG.

Front Cell Dev Biol. 2018 Apr 20;6:44. doi: 10.3389/fcell.2018.00044. eCollection 2018. Review.

13.

Cancer cells exhibit clonal diversity in phenotypic plasticity.

Mathis RA, Sokol ES, Gupta PB.

Open Biol. 2017 Feb;7(2). pii: 160283. doi: 10.1098/rsob.160283.

14.

Heterogeneity and Plasticity of Breast Cancer Stem Cells.

Sousa B, Ribeiro AS, Paredes J.

Adv Exp Med Biol. 2019;1139:83-103. doi: 10.1007/978-3-030-14366-4_5. Review.

PMID:
31134496
15.

Interrogation of Phenotypic Plasticity between Epithelial and Mesenchymal States in Breast Cancer.

Bhatia S, Monkman J, Blick T, Pinto C, Waltham M, Nagaraj SH, Thompson EW.

J Clin Med. 2019 Jun 21;8(6). pii: E893. doi: 10.3390/jcm8060893.

16.

Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance.

Xue Y, Hou S, Ji H, Han X.

Protein Cell. 2017 Mar;8(3):178-190. doi: 10.1007/s13238-016-0330-1. Epub 2016 Oct 18. Review.

17.

Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.

Prabhu A, Kesarwani P, Kant S, Graham SF, Chinnaiyan P.

Neuro Oncol. 2017 Nov 29;19(12):1599-1606. doi: 10.1093/neuonc/nox100.

18.

Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq.

Karaayvaz M, Cristea S, Gillespie SM, Patel AP, Mylvaganam R, Luo CC, Specht MC, Bernstein BE, Michor F, Ellisen LW.

Nat Commun. 2018 Sep 4;9(1):3588. doi: 10.1038/s41467-018-06052-0.

19.

Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity.

Jolly MK, Kulkarni P, Weninger K, Orban J, Levine H.

Front Oncol. 2018 Mar 6;8:50. doi: 10.3389/fonc.2018.00050. eCollection 2018. Review.

20.

Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma.

Reinartz R, Wang S, Kebir S, Silver DJ, Wieland A, Zheng T, Küpper M, Rauschenbach L, Fimmers R, Shepherd TM, Trageser D, Till A, Schäfer N, Glas M, Hillmer AM, Cichon S, Smith AA, Pietsch T, Liu Y, Reynolds BA, Yachnis A, Pincus DW, Simon M, Brüstle O, Steindler DA, Scheffler B.

Clin Cancer Res. 2017 Jan 15;23(2):562-574. doi: 10.1158/1078-0432.CCR-15-2089. Epub 2016 Aug 12.

Supplemental Content

Support Center